| [1] |
Deplazes P, Rinaldi L, Alvarez Rojas CA, et al. Global distribution of alveolar and cystic echinococcosis[J]. Adv Parasitol, 2017(95):315-493.
|
| [2] |
Li B, Quzhen G, Xue CZ, et al. Epidemiological survey of echinococcosis in Tibet Autonomous Region of China[J]. Infect Dis Poverty, 2019, 8(1):29.
|
| [3] |
He W, Wang LY, Yu WJ, et al. Prevalence and spatial distribution patterns of human echinococcosis at the township level in Sichuan Province, China[J]. Infect Dis Poverty, 2021, 10(1):13.
|
| [4] |
Brunetti E, Kern P, Vuitton DA, et al. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans[J]. Acta Trop, 2010, 114(1):1-16.
|
| [5] |
中国医师协会外科医师分会包虫病外科专业委员会. 肝两型包虫病诊断与治疗专家共识(2019版)[J]. 中华消化外科杂志, 2015, 14(4):253-264.
|
| [6] |
Mcmanus DP, Gray DJ, Zhang W, et al. Diagnosis, treatment, and management of echinococcosis[J]. BMJ, 2012(344):e3866.
|
| [7] |
Agudelo Higuita NI, Brunetti E, Mccloskey C. Cystic echinococcosis[J]. J Clin Microbiol, 2016, 54(3):518-523.
|
| [8] |
Stojković M, Weber TF, Junghanss T. Clinical management of cystic echinococcosis: state of the art and perspectives[J]. Curr Opin Infect Dis, 2018, 31(5):383-392.
|
| [9] |
Saidi F, Habibzadeh F. The non-operative management of asymptomatic liver hydatids: ending echinococcophobia[J]. J Gastrointest Surg, 2018, 22(3): 486-495.
|
| [10] |
Kamiyama T. Recent advances in surgical strategies for alveolar echinococcosis of the liver[J]. Surg Today, 2020, 50(11):1360-1367.
|
| [11] |
Azizi A, Blagosklonov O, Lounis A, et al. Alveolar echinococcosis: correlation between hepatic MRI findings and FDG-PET/CT metabolic activity[J]. Abdom Imaging, 2015, 40(1):56-63.
|
| [12] |
Lötsch F, Waneck F, Auer H, et al. FDG-PET/MRI in alveolar echinococcosis[J]. Int J Infect Dis, 2017(64):67-68.
|
| [13] |
何洋，王文涛. 肝泡型棘球蚴病的手术多模式治疗研究进展[J]. 中国普外科基础与临床杂志, 2021, 28(9):1243-1248.
|
| [14] |
Yang C, He J, Yang X, et al. Surgical approaches for definitive treatment of hepatic alveolar echinococcosis: results of a survey in 178 patients[J]. Parasitology, 2019, 146(11): 1414-1420.
|
| [15] |
Qiu Y, Yang X, Shen S, et al. Vascular infiltration-based surgical planning in treating end-stage hepatic alveolar echinococcosis with ex vivo liver resection and autotransplantation[J]. Surgery, 2019, 165(5):889-896.
|
| [16] |
Yang X, Wang T, Kong J, et al. Resection of retrohepatic inferior vena cava without reconstruction in ex vivo liver resection and autotransplantation: a retrospective study[J]. BMC surg, 2020, 20(1): 56.
|
| [17] |
Yang X, Qiu Y, Huang B, et al. Novel techniques and preliminary results of ex vivo liver resection and autotransplantation for end-stage hepatic alveolar echinococcosis: a study of 31 cases[J]. Am J Transplant, 2018, 18(7):1668-1679.
|
| [18] |
Aji T, Dong JH, Shao YM, et al. Ex vivo liver resection and autotransplantation as alternative to allotransplantation for end-stage hepatic alveolar echinococcosis[J]. J Hepatol, 2018, 69(5):1037-1046.
|
| [19] |
Wen H, Dong JH, Zhang JH, et al. Ex vivo liver resection followed by autotransplantation for end-stage hepatic alveolar echinococcosis[J]. Chin Med J (Engl), 2011, 124(18):2813-2817.
|
| [20] |
Zavoikin VD, Zelya OP, Tumolskaya NI. The importance of uninterrupted albendazole treatment in patients with unresectable alveolar echinococcosis undergoing liver transplantation echinococcosis and liver transplantation[J]. Transpl Infect Dis, 2020, 22(4):e13291.
|
| [21] |
Zhang Y, Xie P, Yang C, et al. The value of hepatic vein stent placement as a bridge therapy on treating hepatic alveolar echinococcosis presenting with Budd-Chiari syndrome[J]. Ann Surg, 2021, 273(4):e154-156.
|
| [22] |
Fabbri J, Pensel PE, Albani CM, et al. Albendazole solid dispersions against alveolar echinococcosis: a pharmacotechnical strategy to improve the efficacy of the drug[J]. Parasitology, 2020, 147(9): 1026-1031.
|
| [23] |
李海涛，单骄宇，邵英梅，等. 阿苯达唑脂质体和阿苯达唑片治疗囊型包虫病的临床疗效及安全性[J]. 中华肝脏病杂志, 2011, 19(7):532-536.
|